Inhaled Insulin Licensed in the US

The US Food and Drug Administration (FDA) has approved a rapid acting inhaled insulin for use at mealtimes by adults with diabetes mellitus.

The product, which will be marketed as Afrezza (insulin human) Inhalation Powder, must be used in combination with long acting insulin in people with type 1 diabetes, the FDA warned.

Fitness professionals wishing to read up on this product should view the following documents on the FDA website:

Pfizer did make an inhaled insulin, known as Exubera, for a while during 2005-2008 but discontinued 25 January 2008.

For an overview of inhaled insulin view the article by Lutz Heinemann ‘The Failure of Exubera: Are We Beating a Dead Horse?‘ published in 2008 in the Journal of Diabetes Science and Technology. May 2008. Volume 2(3), pp.518-529.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.